Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count...

FDA Recall #D-099-2013 — Class II — October 4, 2012

Recall #D-099-2013 Date: October 4, 2012 Classification: Class II Status: Terminated

Product Description

Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.

Reason for Recall

Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Recalling Firm

Hospira, Inc. — Lake Forest, IL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

120,350 vials

Distribution

Nationwide

Code Information

Lot #: 14-277-DK*, Exp 02/01/14; * may be followed by 01

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated